Frontlight ResearchEarly access
TerminatedNo phase
Drainless Robot-assisted Minimally Invasive Esophagectomy
Key facts
- Who runs it
- Technische Universität Dresden
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 49 people enrolled
- Started
- 19 Apr 2023
- Ended
- 21 May 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Early removal of chest drain
- Chest drain
- Record updated
- 13 June 2024
- Why it stopped
- Following a safety analysis and assessment of the complications encountered by external experts, it was decided to terminate recruitment prematurely
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Patients scheduled for elective RAMIE for esophageal cancer with intrathoracic esophagogastrostomy (Ivor-Lewis)
- American Society of Anesthesiologists (ASA) score ≤ III
- Eastern Cooperative of Oncology Group (ECOG) status ≤ II
- Patient suitable for both surgical techniques
- Ability of subject to understand character and individual consequences of the clinical trial
- Written informed consent
Who cannot take part
- Simultaneous lung resection
- Chronic pain syndromes requiring routine analgesics
- Presence of contraindications to the use of epidural anesthesia (e.g. coagulopathies, anticoagulation or allergies)
- Open esophagectomy (either abdominal or during the thoracic part)
- Emergency operations
- ASA IV
- ECOG > II
- Participation in an interventional trial, which interferes with the outcome
- Impaired mental state
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is the evaluation of two different chest drain management strategies in patients undergoing robot-assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer with regard to perioperative complications until discharge.The primary objective of the study is to investigate whether the intensity of postoperative pain can be significantly reduced by avoiding thoracic drains after RAMIE. We assume that this will influence secondary endpoints such as early recovery and length of hospital stay.
The 2 groups in the trial
- A - Early removal of chest drainTreatment being tested
Treatment: Early removal of chest drain
- B - ControlOther group
Treatment: Chest drain
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 13 June 2024